EIF2AK3 and cancer: They showed that these drug-resistant cells are specifically sensitive to PERK inhibition, revealing a chemotherapeutic drug-resistant cancer cell vulnerability in PERK and suggesting PERK as a potential target for cancer therapy, specifically in the context of drug-resistant cancers58.